A genetic and viral load analysis of the simian immunodeficiency virus during the acute phase in macaques inoculated by the vaginal route.
about
Blocking HIV-1 transmission in the female reproductive tract: from microbicide development to exploring local antiviral responsesImmunization with a live, attenuated simian immunodeficiency virus vaccine leads to restriction of viral diversity in Rhesus macaques not protected from pathogenic challenge.Shortening of the symptom-free period in rhesus macaques is associated with decreasing nonsynonymous variation in the env variable regions of simian immunodeficiency virus SIVsm during passage.Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection.Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques.Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine.Differential selection of specific human immunodeficiency virus type 1/JC499 variants after mucosal and parenteral inoculation of chimpanzees.Role of maternal autologous neutralizing antibody in selective perinatal transmission of human immunodeficiency virus type 1 escape variants.Turnover of env variable region 1 and 2 genotypes in subjects with late-stage human immunodeficiency virus type 1 infectionDifferential innate immune responses to low or high dose oral SIV challenge in Rhesus macaquesIn vivo selection of CD4(+) T cells transduced with a gamma-retroviral vector expressing a single-chain intrabody targeting HIV-1 tat.Microbicides and other topical strategies to prevent vaginal transmission of HIV.Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques.Influence of naturally occurring simian foamy viruses (SFVs) on SIV disease progression in the rhesus macaque (Macaca mulatta) model.Early detection of simian immunodeficiency virus in the central nervous system following oral administration to rhesus macaques.Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection.Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques.Sex differences in immune responses to infectious diseases.Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assayIdentification of Friend murine retrovirus-infected immune cells and studies of the effects of sex and steroid hormones in the early phase of infection.Vaginal shedding of hepatitis C virus.Human immunodeficiency virus receptor and coreceptor expression on human uterine epithelial cells: regulation of expression during the menstrual cycle and implications for human immunodeficiency virus infection.Mucosal challenge with cell-associated or cell-free feline immunodeficiency virus induces rapid and distinctly different patterns of phenotypic change in the mucosal and systemic immune systems.
P2860
Q26774878-9BDBFF44-DAE6-4294-BAED-D34415F59082Q33648433-9F69DD20-B3DA-48ED-B115-51BD3ECCC975Q33783949-B29B13DD-1B66-4217-80B2-55A34663B1EEQ33813926-D56DCD2B-3111-4449-BDC1-D5B2B99E0571Q33851266-C9388F48-0591-4348-B53B-CE74656C33F6Q34333402-85ED1B50-718D-42C4-85C4-008508F0C0E3Q34357324-77BDF225-4DCD-4D28-B33C-2A3782345203Q34717113-0D432478-3887-49C8-8FD1-AA952D4D49C7Q35020053-19DAD043-5794-449F-B3DD-FD3A5C714EBCQ35915659-B366CFA5-9992-47BD-9EF1-7A2127615CB1Q36228890-7FCA3765-D6E2-43D1-9387-FAA65BAF0D91Q36460440-DE4C018D-6E55-4ED7-AD94-80CA5044CE36Q37010374-FD5C1B17-1E6F-44D6-B156-97B12DCF5115Q37030695-63A7C287-6973-444B-B790-26BE0D044866Q37094265-6C66AFCD-57CF-49B1-9DF3-8DE760179D9FQ37280240-8793AD8C-E323-417A-8394-CEAD5766611DQ37568289-59D74839-B29D-49C9-8226-09F2B49433ADQ37743813-4DEB0E22-2EE6-4FBC-9822-3230839FBF39Q38468493-A8870DF1-6BC8-4AAE-8A91-3A7550B1B75AQ40909665-FF933C65-9056-480E-91CE-874446ACBF82Q42835408-4DB825C0-B399-4360-9BDB-00C94A4E56CFQ43034775-A95135F6-9B4B-4AF4-8B6A-89EEB915EB9BQ44412688-7E9DA977-092A-49B5-9F29-1051992CD033Q44870958-A768B203-EF62-4A74-97E1-8DE888ABEFC1
P2860
A genetic and viral load analysis of the simian immunodeficiency virus during the acute phase in macaques inoculated by the vaginal route.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
A genetic and viral load analy ...... oculated by the vaginal route.
@en
A genetic and viral load analy ...... oculated by the vaginal route.
@nl
type
label
A genetic and viral load analy ...... oculated by the vaginal route.
@en
A genetic and viral load analy ...... oculated by the vaginal route.
@nl
prefLabel
A genetic and viral load analy ...... oculated by the vaginal route.
@en
A genetic and viral load analy ...... oculated by the vaginal route.
@nl
P2093
P356
P1476
A genetic and viral load analy ...... oculated by the vaginal route.
@en
P2093
P304
P356
10.1089/AID.1998.14.171
P577
1998-01-01T00:00:00Z